The Observer science quiz 2013: answers to parts 2 and 3

How did you get on with our annual brainteaser? Check your answers to parts 2 and 3 hereIN THE NEWS21. California; 22. Canada; 23. Lung cancer; 24. Francis Crick; 25. Lake Vostok; 26. 6m tonnes; 27. Henrietta Lack; 28. 100m years; 29. Primate; 30. Mangalyaan; 31. 30 years; 32. 1799; 33. Ununpentium; 34. A full hand transplant; 35. Pakistan; 36. Olinguito; 37. 12bn miles (19bn kilometres); 38. They said they had cured a child of HIV; 39. Arctic Sunrise; 40. Paris.ASTEROIDS, METEORS AND COMETS41. 17,200 miles; 42. 2046; 43. Chelyabinsk; 44. 500; 45. 0.05%; 46. Swift-Tuttle; 47. Chinese; 48. C/2012 S1; 49. It had 6 tails; 50. Origins, Spectral Interpretation, Resource Identification, Security and Regolith Explorer.WHO SAID?51. David Attenborough; 52. Owen Patterson; 53. Richard Dawkins (below); 54. Nigel Lawson; 55. Peter Higgs; 56. Robert Edwards; 57. Australian PM Tony Abbott; 58. Susan Greenfield; 59. Chris Hadfield; 60. Prince Philip.PICTURE GALLERY61. Tian Tian; 62. Virginia McKenna; 63. Ig Nobel prize in Medicine 2013; 64. Iran; 65. Utah; 66. Angela Merkel; 67. Cuadrilla Resources; 68. The oldest bird; 69. 14,055%; 70. First cross‑continental flight in a solar-powered plane.Josh Davistheguardian.com © 2013 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms &Conditions | More Feeds
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Editorial The Observer Science Source Type: news

Related Links:

Publication date: Available online 27 May 2020Source: Respiratory Medicine Case ReportsAuthor(s): Lea Deterding, Tina Körner, Gudrun Borte, Hubert Wirtz, Hans-Jürgen Seyfarth
Source: Respiratory Medicine Case Reports - Category: Respiratory Medicine Source Type: research
Authors: Hung LVM, Ngo HT, Van Pham P Abstract The idea of utilizing the human immune system to eradicate tumors has been successfully practiced for the past decades, as reported in multiple published studies. Among cancer types, non-small cell lung cancer (NSCLC) is considered the most lethal type, leading to the necessity of finding an effective treatment for this category of cancer. Building on the success of basic and preclinical studies, numerous clinical trials of cytokine-induced killer (CIK) cells or chimera antigen receptor (CAR) T cells for NSCLC therapy have been reported. In this review paper, we will s...
Source: Advances in Experimental Medicine and Biology - Category: Research Tags: Adv Exp Med Biol Source Type: research
Abstract INTRODUCTION: A pandemic coronavirus, SARS-CoV-2, causes COVID-19, a potentially life-threatening respiratory disease. Patients with cancer may have compromised immunity due to their malignancy and/or treatment, and may be at elevated risk of severe COVID-19. Community transmission of COVID-19 could overwhelm health care services, compromising delivery of cancer care. This interim consensus guidance provides advice for clinicians managing patients with cancer during the pandemic. MAIN RECOMMENDATIONS: During the COVID-19 pandemic: In patients with cancer with fever and/or respiratory symptoms, consid...
Source: Med J Aust - Category: General Medicine Authors: Tags: Med J Aust Source Type: research
We are delighted with the interest shown for our article “Lung cancer surgical treatment after solid organ transplantation: a single center 30-year experience” [1] and thank the authors for taking the time to comment on it [2].
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
We read with interest the article entitled “Lung cancer surgical treatment after solid organ transplantation: A single center 30-year experience”.1 We applaud Dr. Drevet et al.’s report on outcomes of surgery in lung cancer patients after a solid organ transplantation.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
Conclusion: Cavin3 was highly expressed in lung cancer, and it was capable to promote cell proliferation, invasion, and migration. PMID: 32352004 [PubMed - in process]
Source: Biomed Res - Category: Research Authors: Tags: Biomed Res Int Source Type: research
This study reveals that the gut microbiota functions as a protective regulator against radiation pneumonitis. Additionally, fecal microbiota transplantation was shown to alleviate lung injury in the irradiated model. The protective role of the healthy gut microbiota and the utilization of the gut-lung axis show potential for innovative therapeutic strategies in radiation-induced lung injury. PMID: 32330075 [PubMed - as supplied by publisher]
Source: Radiation Research - Category: Physics Authors: Tags: Radiat Res Source Type: research
CONCLUSION: Although tumor burden has been considered a mediator of efficacy of earlier immunotherapies, in advanced lung cancer it does not appear to affect outcomes from immune checkpoint inhibitors. IMPLICATIONS FOR PRACTICE: Historically, tumor burden has been considered an impediment to the efficacy of various immunotherapies, including vaccines, cytokines, allogeneic stem cell transplant, and intravesical bacillus Calmette-Guérin. However, in the present study, no association was found between tumor burden and efficacy (response rate, progression-free survival, overall survival) of immune checkpoint inhib...
Source: The Oncologist - Category: Cancer & Oncology Authors: Tags: Oncologist Source Type: research
Abstract BACKGROUND: Hepatocellular carcinoma (HCC) recurrence and development of de novo malignancy (DNM) after liver transplantation (LT) are the major causes of late recipient death. METHODS: We analyzed the incidence of extrahepatic DNM following living donor LT according to the status of pretransplant hepatic malignancy. We selected 2,076 adult patients who underwent primary LDLT during 7 years from January 2010 to December 2016. RESULTS: The pretransplant hepatic malignancy group (n = 1,012) showed 45 cases (4.4%) of the following extrahepatic DNMs: posttransplant lymphoproliferative disease (PTLD)...
Source: J Korean Med Sci - Category: General Medicine Authors: Tags: J Korean Med Sci Source Type: research
AbstractObjective: To study the effect and mechanism of Huayu Wan ( 化瘀丸, HYW) in combination of chemotherapy of tumor treatment.Methods: HYW serum was added in Lewis cells to assess its impact on fluorescent doxorubicin delivery in vitro. Then, Lewis tumor cells was implanted in C57BL/6 mice via xenograft transplantation. Tumor growth was measured and signal intensity corresponding to blood flow was assessed by laser doppler perfusion imaging (LDPI). Finally, the effect of HYW on the effificacy of doxorubicin was studied.Results: HYW can improve the transfer of fluorescent doxorubicin into cells. The blood flow signa...
Source: Chinese Journal of Integrative Medicine - Category: Internal Medicine Source Type: research
More News: Cancer | Cancer & Oncology | Children | Legislation | Lung Cancer | Lung Transplant | Middle East Health | Science | Transplant Surgery | Transplants